Immatics Raises €54 Million Series C To Fund Pivotal Therapeutic Cancer Vaccine Trial
One of the largest European fundraisings this year, the round will help advance a potential therapeutic vaccine for kidney cancer through Phase III.
One of the largest European fundraisings this year, the round will help advance a potential therapeutic vaccine for kidney cancer through Phase III.